Molecular Testing in Diagnosis and Prognosis – Challenging Oncology Cases

May 18, 2022

Haythem Riahi, Ph.D., M.B.A.

International Clinical Specialty Liaison - Hematology & Oncology
Mayo Clinic Laboratories
Importance of Molecular Testing in Diagnosing and Determining Prognosis of Lung Cancer – Updates and Challenging CasesYing-Chun Lo, M.D., Ph.D.
Senior Associate Consultant
Division of Anatomic Pathology
Mayo Clinic
Molecular Neurooncology/NeuropathologyRobert B. Jenkins, M.D., Ph.D.
Consultant, Division of Laboratory Genetics and Genomics, Mayo Clinic
Brain Tumor Diagnosis and Approach – Case DiscussionRawia Mubarak Mohamed, MBBS, FRCPA
Consultant, Anatomical Pathologist, Sheikh Shakhbout Medical City
Clinical Associate Professor, Department of Pathology, College of Medicine and Health Sciences, Khalifa University